Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration (Q40851487)

24 September 2017

Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration (English)

1 reference

24 September 2017

1 reference

1 reference

J Lötsch

1

0 references

author name string

M Weiss

series ordinal

2

1 reference

24 September 2017

G Kobal

series ordinal

3

1 reference

24 September 2017

G Geisslinger

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

Clinical Pharmacology & Therapeutics

24 September 2017

1 reference

24 September 2017

63

1 reference

24 September 2017

6

1 reference

24 September 2017

629-639

1 reference

Gene expression in oestrogen-dependent human breast cancer xenograft tumours

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

The analgesic activity of morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Pharmacological mechanisms of opioid analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Lack of Analgesic Activity of Morphine-6-glucuronide after Short-term Intravenous Administration in Healthy Volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Chronic nausea and morphine-6-glucuronide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Analysis of morphine and its 3- and 6-glucuronides by high performance liquid chromatography with fluorimetric detection following solid phase extraction from neonatal plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Fast reliable assay for morphine and its metabolites using high-performance liquid chromatography and native fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Determination of pharmacokinetic constants after multiple infusions of drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Disposition kinetics of lidocaine in normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

A general model of metabolite kinetics following intravenous and oral administration of the parent drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

The relevance of residence time theory to pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Disposition of morphine-6-glucuronide and morphine in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Extrahepatic metabolism of morphine occurs in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Membrane transport as a determinant of the hepatic elimination of drugs and metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

Oral morphine in cancer pain: influences on morphine and metabolite concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990086-8

10.1016/S0009-9236(98)90086-8

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference